Hilde Lavreysen
Janssen (Belgium)(BE)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, Electroconvulsive Therapy Studies, Pharmacological Effects and Toxicity Studies, Schizophrenia research and treatment
Most-Cited Works
- → JNJ16259685, a highly potent, selective and systemically active mGlu1 receptor antagonist(2004)138 cited
- → Biased mGlu 5 -Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu 5 Modulation of NMDAR Currents(2015)128 cited
- → Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function(2011)127 cited
- → [3H]R214127: A Novel High-Affinity Radioligand for the mGlu1 Receptor Reveals a Common Binding Site Shared by Multiple Allosteric Antagonists(2003)115 cited
- → Summary of Product Characteristics(2010)106 cited
- → Effects of mGlu1 receptor blockade on anxiety-related behaviour in the rat lick suppression test(2004)90 cited
- → Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor(2012)85 cited
- → Therapeutic Potential of Group III Metabotropic Glutamate Receptors(2008)81 cited
- → Metabotropic glutamate 1 receptor distribution and occupancy in the rat brain: a quantitative autoradiographic study using [3H]R214127(2004)81 cited
- → Characterization of 2-[[4-Fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor(2010)76 cited